Glucose free primary anticoagulant for blood containing citrate ions
US4925665A · kind A · utility
32Cited by
3References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 22, 1989 |
| Grant date | May 15, 1990 |
| Priority date | — |
| Expiry date | Jun 22, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel primary citrate anticoagulant which is essentially free of glucose and its use to optimize the viability of stored platelets. The present invention allows platelets to be stored in plasma or synthetic media without the addition of buffer. Specifically the anticoagulant consists essentially of sodium citrate and citric acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.